GLS2 is overexpressed in cervical cancer tissues of radioresistant patients, and in vitro GLS2 knockdown reverses the radioresistant phenotype of different cancer cell lines by reducing GSH and NADH levels, and, therefore, increasing intracellular ROS levels [117]. Here, GLS2 is linked to cervical cancer.